CN103520362B - Heart and brain capsule improves application in medicine preparing learning memory disorder - Google Patents

Heart and brain capsule improves application in medicine preparing learning memory disorder Download PDF

Info

Publication number
CN103520362B
CN103520362B CN201310397188.3A CN201310397188A CN103520362B CN 103520362 B CN103520362 B CN 103520362B CN 201310397188 A CN201310397188 A CN 201310397188A CN 103520362 B CN103520362 B CN 103520362B
Authority
CN
China
Prior art keywords
memory
mice
xinnaoxin jiaonang
xinnaoxin
jiaonang
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201310397188.3A
Other languages
Chinese (zh)
Other versions
CN103520362A (en
Inventor
马俊仓
邹存生
李成秀
张国清
夏彬
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gansu Qizheng Tibetan Medicine Co Ltd
Original Assignee
S&P PHARMA Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S&P PHARMA Co Ltd filed Critical S&P PHARMA Co Ltd
Priority to CN201310397188.3A priority Critical patent/CN103520362B/en
Publication of CN103520362A publication Critical patent/CN103520362A/en
Application granted granted Critical
Publication of CN103520362B publication Critical patent/CN103520362B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses XINNAOXIN JIAONANG preparing learning memory disorder improves application in medicine.XINNAOXIN JIAONANG causes learning memory disorder model mice ability of learning and memory to scopolamine and has improvement result, and its mechanism of action is the effect of XINNAOXIN JIAONANG by m receptor, and the activity of suppression scopolamine etc. are relevant.

Description

Heart and brain capsule improves application in medicine preparing learning memory disorder
Technical field
The invention belongs to field of medicaments, be specifically related to XINNAOXIN JIAONANG preparing learning memory disorder and improve application in medicine.
Background technology
Study, memory function comprise Spatial memory function and non-space learning and memory function.Dysmnesia model is the effective means that evaluation medicine affects Memory Process, is also the model that discussion Drug therapy senile dementia effect and mechanism of action often adopt.Scopolamine is m receptor blocker, and energy blockage of acetylcholine, to the agonism of m receptor, can be simulated acetylcholine hyposecretion and cause damage in learning and memory.Sodium nitrite can make hemoglobin degeneration, makes brain tissue ischemia anoxia, infringement learning and memory process.Ethanol suppresses corticocerebral function of nervous system movable, and suppress the trained reflex process of animal, make brain internal protein and RNA biosynthesis block, the system such as cholinergic and dopamine changes, and destroys learning and memory function and causes learning and memory to reproduce obstacle.
XINNAOXIN JIAONANG is S&P Pharmaceutical Co., Ltd.'s product, and the accurate word Z20025866 of traditional Chinese medicines, cures mainly supplementing QI and nourishing YIN, blood circulation promoting and blood stasis dispelling.But have not been reported in the effect of learning memory disorder.
Summary of the invention
Goal of the invention: the new opplication that the object of the present invention is to provide XINNAOXIN JIAONANG.
Technical scheme: the invention discloses XINNAOXIN JIAONANG preparing learning memory disorder and improve application in medicine.
Above-mentioned XINNAOXIN JIAONANG is the Radix Rhodiolae of 3 ~ 6 parts by parts by weight, the Fructus Lycii of 5 ~ 15 parts, the Fructus Hippophae composition of 3 ~ 9 parts.
Beneficial effect: show after deliberation, XINNAOXIN JIAONANG causes learning memory disorder model mice ability of learning and memory to scopolamine and has improvement result, and its mechanism of action is the effect of XINNAOXIN JIAONANG by m receptor, and the activity of suppression scopolamine etc. are relevant.
Detailed description of the invention
Embodiment 1:
XINNAOXIN JIAONANG causes memory dysfunction to be improved to chemicals
1 material
1.1 reagent and instrument
XINNAOXIN JIAONANG is purchased from S & P Pharmaceutical Co., Ltd. (lot number 120803); Nimodipine tablet is purchased from Bayer HealthCare Co (lot number BJ09103); Scopolamine hydrobromide alkali is purchased from Sigma-Aldrich(lot number SLBD0119V); Ethanol is purchased from Chemical Reagent Co., Ltd., Sinopharm Group (lot number 20100827); Sodium nitrite is purchased from Nanjing Chemistry Reagent Co., Ltd. (lot number 12060410920).Electronic balance (Beijing Sai Duolisi balance company limited), XT-911 type mice diving tower trained reflex tester (manufacture of Shanghai The 2nd Army Medical College), channel-type water maze
1.2 animal
For examination animal cleaning grade ICR mice, body weight 18-22g, 180, provided by Yangzhou University's comparative medicine center, laboratory animal production licence: SCXK(revives) 2012-0004.Conventional Mus forage feed, freely drinks water.Before experiment, in quiet environment, adaptability is raised 1 week, drinking-water of freely ingesting, and keeps room temperature (22 ± 1 DEG C), natural circadian rhythm illumination.
2 methods
2.1 impacts on scopolamine induced mice memory acquisition disturbance
Mice random packet, if the high, medium and low dosage group of XINNAOXIN JIAONANG, blank group gives isometric(al) distilled water respectively with model group, and positive controls gives nimodipine 30mg/kg, each group difference every day gavage 1 time, successive administration 7 days.
Train by conventional medical research animal model.By XT-911 type mice diving tower trained reflex tester Control of Voltage at 36V, after 1 hour, carry out the test of learning and memory of little mouse function in last administration.Train first 10 minutes model group and administration group lumbar injection scopolamine hydrobromide 0.5mg/kg respectively, the capacity normal saline such as blank group lumbar injection.Often criticize and have 4 mice administrations respectively, operation repetitive, give the 2nd batch of injected in mice again after 10 minutes, by that analogy.To often criticize 4 mices and put into respectively 4 grid of diving tower instrument during training, first conform 3 minutes, be then energized, after mice is shocked by electricity, majority jumps onto diving tower, escapes electric shock.Contacting copper grid for getting an electric shock with mice biped when jumping off simultaneously, being considered as wrong reaction, training 5 minutes, retest after 24 hours.
First be placed on diving tower by mice during test, start timing simultaneously, record mice first time jumps off the time, and this for getting an electric shock incubation period (being error latence), and records in 5 minutes and jump off number of times (being errors number), as observation index.
2.2 impacts on sodium nitrite induced mice remember consolidation disorders
Grouping, administration and training method are with experiment 2.1.Except blank group subcutaneous injection normal saline after training terminates, all the other respectively organize subcutaneous injection sodium nitrite 120mg/kg immediately, test after 24 hours.Method of testing is also with experiment 2.1.
2.3 on 40% ethanol induced mice reproducibility dysmnesia impact
Grouping, administration and training method are with experiment 2.1.Test first 30 minutes, model group and administration group be gavage 40% ethanol 10ml/kg respectively, and blank group gives isometric(al) distilled water.Method of testing is also with experiment 2.1.
3 results
3.1 XINNAOXIN JIAONANG are on the impact of scopolamine induced mice memory acquisition disturbance
3.1.1 give 7d XINNAOXIN JIAONANG (170,340,680mg/kg) continuously, scopolamine induced mice memory acquisition disturbance mice, in channel-type water maze Memory result, XINNAOXIN JIAONANG high dose group can obviously shorten find platform incubation period ( *p<0.01), significantly reduce errors number ( *p<0.01).The results are shown in Table 1.3.1.2 give 7d XINNAOXIN JIAONANG (170,340,680mg/kg) continuously, in mice diving tower Memory result, each dosage group of XINNAOXIN JIAONANG all obviously can extend incubation period, reduce errors number ( *p<0.01).The results are shown in Table 2.
Table 1 XINNAOXIN JIAONANG on the impact of scopolamine induced mice memory acquisition disturbance (channel-type water maze, n=10)
Compare with blank group: #P<0.05, ##P<0.01; Compare with model group: *p<0.05, *p<0.01
Table 2 XINNAOXIN JIAONANG on the impact of scopolamine induced mice memory acquisition disturbance (diving tower, n=10)
Compare with blank group: #P<0.05, ##P<0.01; Compare with model group: *p<0.05, *p<0.01
3.2 XINNAOXIN JIAONANG are on the impact of 40% ethanol induced mice memory acquisition disturbance
3.2.1 7d XINNAOXIN JIAONANG (170,340,680mg/kg) is given continuously, to in 40% ethanol induced mice memory acquisition disturbance mouse experiment, each dosage group of XINNAOXIN JIAONANG can obviously reduce 40% ethanol modeling mice channel-type water maze incubation period and errors number ( *p<0.01).The results are shown in Table 3.
Table 3 XINNAOXIN JIAONANG on the impact of 40% ethanol induced mice memory acquisition disturbance (channel-type water maze,
n=10)
Compare with blank group: #P<0.05, ##P<0.01; Compare with model group: *p<0.05, *p<0.01
3.2.2 give 7d XINNAOXIN JIAONANG (170,340,680mg/kg) continuously, in 40% ethanol induced mice memory acquisition disturbance mice Jumping test, XINNAOXIN JIAONANG high dose group obviously can extend incubation period and reduce errors number ( *p<0.05).The results are shown in Table 4.
Table 4 XINNAOXIN JIAONANG on the impact of 40% ethanol induced mice memory acquisition disturbance (diving tower, n=10)
Compare with blank group: #P<0.05, ##P<0.01; Compare with model group: *p<0.05, *p<0.01
3.3 XINNAOXIN JIAONANG are on the impact of sodium nitrite induced mice memory acquisition disturbance
3.3.1 give 7d XINNAOXIN JIAONANG (170,340,680mg/kg) continuously, in sodium nitrite modeling mice channel-type water maze laboratory, XINNAOXIN JIAONANG can obviously reduce model mice find outlet errors number ( *p<0.05).The results are shown in Table 5.
Table 5 XINNAOXIN JIAONANG on the impact of sodium nitrite induced mice memory acquisition disturbance (channel-type water maze, n=10)
Compare with blank group: #P<0.05, ##P<0.01; Compare with model group: *p<0.05, *p<0.01
3.3.2 give 7d XINNAOXIN JIAONANG (170,340,680mg/kg) continuously, in sodium nitrite modeling mice Jumping test, XINNAOXIN JIAONANG does not have obvious effect.The results are shown in Table 6.
Table 6 XINNAOXIN JIAONANG on the impact of sodium nitrite induced mice memory acquisition disturbance (diving tower, n=10)
Compare with blank group: #P<0.05, ##P<0.01; Compare with model group: *p<0.05, *p<0.01
4 conclusions
XINNAOXIN JIAONANG administration group all can shorten the incubation period (P<0.01 or P<0.05) of memory acquisition disturbance model mice caused by scopolamine in various degree; improve spatial memory capacity, reduce and jump off platform and enter cecum errors number (P<0.01); To in 40% ethanol induced mice memory acquisition disturbance mice Jumping test, XINNAOXIN JIAONANG obviously can reduce errors number (P<0.01 or P<0.05), but does not have obvious effect to remember consolidation disorders model caused by sodium nitrite.Summary can obtain XINNAOXIN JIAONANG and be significantly improved memory acquisition disturbance model mice ability of learning and memory caused by scopolamine.

Claims (1)

1. heart and brain capsule improves application in medicine preparing learning memory disorder, it is characterized in that, described heart and brain capsule by parts by weight Radix Rhodiolae 3 ~ 6 parts, Fructus Lycii 5 ~ 15 parts, Fructus Hippophae 3 ~ 9 parts composition.
CN201310397188.3A 2013-09-04 2013-09-04 Heart and brain capsule improves application in medicine preparing learning memory disorder Active CN103520362B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310397188.3A CN103520362B (en) 2013-09-04 2013-09-04 Heart and brain capsule improves application in medicine preparing learning memory disorder

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310397188.3A CN103520362B (en) 2013-09-04 2013-09-04 Heart and brain capsule improves application in medicine preparing learning memory disorder

Publications (2)

Publication Number Publication Date
CN103520362A CN103520362A (en) 2014-01-22
CN103520362B true CN103520362B (en) 2016-03-23

Family

ID=49922949

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310397188.3A Active CN103520362B (en) 2013-09-04 2013-09-04 Heart and brain capsule improves application in medicine preparing learning memory disorder

Country Status (1)

Country Link
CN (1) CN103520362B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104095990A (en) * 2014-06-19 2014-10-15 三普药业有限公司 Application of Xinnaoxin capsule to preparation of medicine for improving elder memory

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1872239A (en) * 2006-04-24 2006-12-06 江西青春康源制药有限公司 Liquid capsule of heart and brain, and preparation method

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
红景天的研究现状;金萍;《光明中医》;20110731;第26卷(第7期);1508-1510 *

Also Published As

Publication number Publication date
CN103520362A (en) 2014-01-22

Similar Documents

Publication Publication Date Title
CN101721567B (en) Grassleaf sweetflag rhizome extract, preparation method and application thereof
CN104225167B (en) Purposes of the LIUWEI DIHUANG TANG extract in treatment dementia or cognition dysfunction
CN104645184A (en) Traditional Chinese medicine composition for treating senile dementia
CN101869600A (en) Medicinal composition for treating degenerative change in central nervous system, preparation method and application thereof
CN103520362B (en) Heart and brain capsule improves application in medicine preparing learning memory disorder
CN104305192B (en) Improve functional food of patients of senile dementia memory and preparation method thereof
CN103040905B (en) Herba arenariae kansuensis or the purposes of its extract in the antidotal medicine of preparation or health food
CN110772610B (en) Plant extract and preparation method and application thereof
EP2470213A1 (en) Composition for treatment of neurodegenerative diseases or disorders, method and use comprising electromagnetically irradiated yeast
CN103417606A (en) Preparation method and application of drug or health product for treatment of impaired learning memory
CN101904894B (en) Application of lamiophlomis rotate total glycosides in preparing medicines
CN102488687A (en) Application of rapamycin to preparation of medicament for treating schizophrenia
CN104224817A (en) Application of panaxadiol saponin component in preparing antischizophrenic drug
CN102940621B (en) Application of methyl ferulic acid in preparation of medicine for preventing and curing hepatic fibrosis
Zhang et al. Efficacy observation on Governor Vessel-regulating and brain-unblocking acupuncture for post-stroke depression
CN106074643B (en) Application of acanthopanax giraldii harms leaf and extract thereof in preparing anti-fatigue medicine or health food
CN106620082B (en) Acorus gramineus extract and preparation method and application thereof
CN1686514A (en) Chinese medicinal preparation for treating anxietas, depression and its production method
CN101785816A (en) Grass-leaved sweetflag extract, medicine composition with grass-leaved sweetflag extract, preparation method and application thereof
CN104130232B (en) The method of purification of a kind of EGCG and the EGCG of acquisition and pharmaceutical composition
CN112439051B (en) Application of cyclic dipeptide in preparation of drugs for treating mental diseases
CN104042677A (en) Use of Manglietia fruit extractive in preparation of orthopaedic anti-inflammatory and analgesic medicine
CN103387580A (en) Stemona root alkaloid monomer components and applications thereof
CN103417664A (en) Application of fructus ziziphi jujubae in preparing medicine or health-care product for treating Alzheimer disease
CN108272917A (en) A kind of Uygur medicine composition and preparation method thereof for treating failure of memory

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20211130

Address after: Is Yuzhong County 730100 Avenue in Lanzhou city in Gansu Province

Patentee after: GANSU QIZHENG TIBETAN MEDICINE Co.,Ltd.

Address before: 810007 No. 58 Delingha Road, Chengdong District, Xining City, Qinghai Province

Patentee before: S&P PHARMACEUTICAL CO.,LTD.

TR01 Transfer of patent right